Cannabis company valuations are volatile. Where they are today is very different from what we saw just a few months ago and likely will be very different a few months from now. This session will hit on these points as well as how you should read valuations in the market.
You’ll get insights on:
- How private-market buyer and seller expectations have changed with the drop in public markets since June.
- How to separate the wheat from the chaff when assessing cannabis businesses.
- How deal structures have changed in response to shifting risk.